NO20033318D0 - 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav - Google Patents

2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav

Info

Publication number: NO20033318D0
Authority: NO; Norway
Prior art keywords: pharmaceutical compositions; manufacture; benzopyran derivatives; preparation; benzopyran
Prior art date: 2001-01-24

Application number

NO20033318A

Other languages

English (en)

Other versions

NO327808B1 (no

NO20033318L (no

Inventor

Maurizio Delcanale

Gabriele Amari

Elisabetta Armani

Maurizio Civelli

Elisabetta Galbiati

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-24

Filing date

2003-07-23

Publication date

2003-07-23

2001-01-24 Priority claimed from EP01101521A external-priority patent/EP1229036B1/en

2001-08-03 Priority claimed from EP01118682A external-priority patent/EP1281710A1/en

2003-07-23 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2003-07-23 Publication of NO20033318D0 publication Critical patent/NO20033318D0/no

2003-09-24 Publication of NO20033318L publication Critical patent/NO20033318L/no

2009-09-28 Publication of NO327808B1 publication Critical patent/NO327808B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)

NO20033318A 2001-01-24 2003-07-23 2H-1-benzopyranderivater, fremgangsmate ved fremstilling samt farmasoytiske sammensetninger derav NO327808B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP01101521A EP1229036B1 (en)	2001-01-24	2001-01-24	2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
EP01118682A EP1281710A1 (en)	2001-08-03	2001-08-03	2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
PCT/EP2002/000567 WO2002059113A1 (en)	2001-01-24	2002-01-21	2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof

Publications (3)

Publication Number	Publication Date
NO20033318D0 true NO20033318D0 (no)	2003-07-23
NO20033318L NO20033318L (no)	2003-09-24
NO327808B1 NO327808B1 (no)	2009-09-28

Family

ID=26076450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033318A NO327808B1 (no)	2001-01-24	2003-07-23	2H-1-benzopyranderivater, fremgangsmate ved fremstilling samt farmasoytiske sammensetninger derav

Country Status (26)

Country	Link
US (1)	US6951883B2 (no)
EP (1)	EP1355906B1 (no)
JP (1)	JP4332349B2 (no)
CN (1)	CN1261431C (no)
AT (1)	ATE286894T1 (no)
AU (1)	AU2002237282B2 (no)
BR (1)	BR0207066A (no)
CA (1)	CA2435775A1 (no)
CZ (1)	CZ20032014A3 (no)
DE (1)	DE60202590T2 (no)
DK (1)	DK1355906T3 (no)
DZ (1)	DZ3459A1 (no)
EA (1)	EA006158B1 (no)
ES (1)	ES2236485T3 (no)
HU (1)	HUP0401018A3 (no)
IL (2)	IL157065A0 (no)
MA (1)	MA26982A1 (no)
MX (1)	MXPA03006505A (no)
NO (1)	NO327808B1 (no)
NZ (1)	NZ527144A (no)
PL (1)	PL365062A1 (no)
PT (1)	PT1355906E (no)
SI (1)	SI1355906T1 (no)
SK (1)	SK287086B6 (no)
TN (1)	TNSN03043A1 (no)
WO (1)	WO2002059113A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2516067T3 (es) *	2004-09-21	2014-10-30	Mei Pharma, Inc.	Derivados de cromano sustituidos, medicamentos y utilización en terapia
JP4976649B2 (ja) *	2004-09-21	2012-07-18	マーシャルエドワーズ，インク．	化合物
AU2005287865B2 (en) *	2004-09-21	2012-02-16	Marshall Edwards, Inc.	Substituted chroman derivatives, medicaments and use in therapy
WO2006032086A1 (en) *	2004-09-21	2006-03-30	Novogen Research Pty Ltd	Chroman derivatives, medicaments and use in therapy
US8080675B2 (en)	2004-09-21	2011-12-20	Marshall Edwards, Inc.	Chroman derivatives, medicaments and use in therapy
AU2005201855B2 (en) *	2004-09-21	2012-03-29	Marshall Edwards, Inc.	Chroman derived compounds and formulations thereof for use in therapy
CN101444499B (zh) *	2007-11-26	2012-12-05	湘北威尔曼制药股份有限公司	一种化合物及其组合物的新用途
WO2012061413A2 (en)	2010-11-01	2012-05-10	Marshall Edwards, Inc.	Isoflavonoid compositions and methods for the treatment of cancer
EA031077B1 (ru)	2013-06-19	2018-11-30	Серагон Фармасьютикалз, Инк.	Модулятор рецептора эстрогена и его применения
AU2016215515B2 (en)	2015-02-02	2020-04-30	Mei Pharma, Inc.	Combination therapies
RU2742278C2 (ru) *	2016-11-17	2021-02-04	Санофи	Новые соединения замещенного n-(3-фторпропил)пирролидина, способы их получения и их терапевтическое применение
EP3681495A4 (en) *	2017-09-15	2021-06-02	Nyrada Pty Limited	TREATMENT OF EXCITOTOXICITY
CN112225716A (zh) *	2020-10-30	2021-01-15	陕西嘉禾生物科技股份有限公司	一种鹰嘴豆牙素a的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3374245A (en) *	1964-04-01	1968-03-19	Ciba Geigy Corp	Unsaturated oxacycles
DE1518002C3 (de) *	1965-01-02	1975-01-23	Merck Patent Gmbh, 6100 Darmstadt	Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
US5280040A (en) *	1993-03-11	1994-01-18	Zymogenetics, Inc.	Methods for reducing bone loss using centchroman derivatives
ZA979643B (en) *	1996-10-28	1998-04-28	Novo Nordisk As	Heterocyclic compounds, compositions and uses.
US5985306A (en)	1996-10-28	1999-11-16	Novo Nordisk A/S	(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
JP3251946B2 (ja)	1996-12-13	2002-01-28	中外製薬株式会社	新規なベンゾピラン誘導体
KR20000001793A (ko) *	1998-06-13	2000-01-15	이경하	신규한 벤조피란 또는 티오벤조피란 유도체
KR100615757B1 (ko)	1998-12-30	2006-08-25	시그날 파마소티칼 아이엔씨	에스트로겐 수용체를 조절하는 화합물 및 방법

2002
- 2002-01-21 AT AT02703564T patent/ATE286894T1/de not_active IP Right Cessation
- 2002-01-21 NZ NZ527144A patent/NZ527144A/en unknown
- 2002-01-21 EP EP02703564A patent/EP1355906B1/en not_active Expired - Lifetime
- 2002-01-21 AU AU2002237282A patent/AU2002237282B2/en not_active Ceased
- 2002-01-21 DK DK02703564T patent/DK1355906T3/da active
- 2002-01-21 HU HU0401018A patent/HUP0401018A3/hu unknown
- 2002-01-21 PL PL02365062A patent/PL365062A1/xx not_active IP Right Cessation
- 2002-01-21 WO PCT/EP2002/000567 patent/WO2002059113A1/en not_active Ceased
- 2002-01-21 DZ DZ023459A patent/DZ3459A1/fr active
- 2002-01-21 SI SI200230096T patent/SI1355906T1/xx unknown
- 2002-01-21 CN CNB02804066XA patent/CN1261431C/zh not_active Expired - Fee Related
- 2002-01-21 CZ CZ20032014A patent/CZ20032014A3/cs unknown
- 2002-01-21 JP JP2002559415A patent/JP4332349B2/ja not_active Expired - Fee Related
- 2002-01-21 EA EA200300727A patent/EA006158B1/ru not_active IP Right Cessation
- 2002-01-21 CA CA002435775A patent/CA2435775A1/en not_active Abandoned
- 2002-01-21 US US10/466,118 patent/US6951883B2/en not_active Expired - Fee Related
- 2002-01-21 DE DE60202590T patent/DE60202590T2/de not_active Expired - Lifetime
- 2002-01-21 IL IL15706502A patent/IL157065A0/xx unknown
- 2002-01-21 BR BR0207066-9A patent/BR0207066A/pt not_active IP Right Cessation
- 2002-01-21 SK SK939-2003A patent/SK287086B6/sk not_active IP Right Cessation
- 2002-01-21 PT PT02703564T patent/PT1355906E/pt unknown
- 2002-01-21 ES ES02703564T patent/ES2236485T3/es not_active Expired - Lifetime
- 2002-01-21 MX MXPA03006505A patent/MXPA03006505A/es active IP Right Grant
2003
- 2003-07-08 TN TNPCT/EP2002/000567A patent/TNSN03043A1/en unknown
- 2003-07-15 MA MA27236A patent/MA26982A1/fr unknown
- 2003-07-23 NO NO20033318A patent/NO327808B1/no not_active IP Right Cessation
- 2003-07-23 IL IL157065A patent/IL157065A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL157065A (en)	2010-05-17
NO327808B1 (no)	2009-09-28
CN1487934A (zh)	2004-04-07
US20040106595A1 (en)	2004-06-03
NZ527144A (en)	2005-03-24
AU2002237282B2 (en)	2007-02-15
CN1261431C (zh)	2006-06-28
SK287086B6 (sk)	2009-11-05
DE60202590T2 (de)	2005-12-29
SK9392003A3 (en)	2003-12-02
EA200300727A1 (ru)	2004-02-26
US6951883B2 (en)	2005-10-04
MA26982A1 (fr)	2004-12-20
CZ20032014A3 (cs)	2003-12-17
CA2435775A1 (en)	2002-08-01
HUP0401018A2 (hu)	2004-09-28
NO20033318L (no)	2003-09-24
SI1355906T1 (en)	2005-06-30
EP1355906A1 (en)	2003-10-29
PT1355906E (pt)	2005-05-31
DE60202590D1 (de)	2005-02-17
BR0207066A (pt)	2004-03-30
JP2004517151A (ja)	2004-06-10
JP4332349B2 (ja)	2009-09-16
DZ3459A1 (fr)	2002-08-01
DK1355906T3 (da)	2005-05-30
EA006158B1 (ru)	2005-10-27
HUP0401018A3 (en)	2007-05-29
ATE286894T1 (de)	2005-01-15
IL157065A0 (en)	2004-02-08
ES2236485T3 (es)	2005-07-16
EP1355906B1 (en)	2005-01-12
PL365062A1 (en)	2004-12-27
TNSN03043A1 (en)	2005-12-23
HK1060558A1 (en)	2004-08-13
MXPA03006505A (es)	2004-04-21
WO2002059113A1 (en)	2002-08-01

Publication	Publication Date	Title
MXPA03010134A (es)	2004-03-10	Derivados de ciclohexan-1-4-diamina sustituidos.
WO2003080582A3 (de)	2004-12-09	Fredericamycin-derivate
MXPA03007983A (es)	2003-12-04	Procedimiento para la preparacion de destilados intermedios.
NL300305I1 (nl)	2008-01-02	Werkwijze voor de bereiding van gesubstitueerde octanoylamides.
NO20042739L (no)	2004-07-23	Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
TWI268278B (en)	2006-12-11	2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
NO20033318L (no)	2003-09-24	2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
MXPA03007635A (es)	2003-12-04	P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
WO2003033557A3 (de)	2003-09-18	Fluorhaltige copolymere, deren herstellung und verwendung
WO2003037863A3 (de)	2004-08-12	Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
DK1118610T3 (da)	2002-12-16	Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
AU2002357740A1 (en)	2003-06-23	Pyrazolo-pyridine derivatives as antiherpes agents
MXPA04004090A (es)	2004-07-08	Compuestos substituidos de 1h-quinolin-2-ona.
PT1406859E (pt)	2008-01-24	Derivados substituídos de 4-aminociclo-hexanol
ATE286893T1 (de)	2005-01-15	2h-1-benzopyran-derivative, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
AP2001002369A0 (en)	2001-12-31	Pharmaceutical complex.
IT1289154B1 (it)	1998-09-29	Derivati di isoflavone loro preparazione e loro impiego terapeutico
EP1436279B8 (en)	2008-10-29	Chemical compounds
MXPA03009210A (es)	2004-01-29	PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
HUP0103686A2 (en)	2002-06-29	Use of rolipram, ariflo or diazepino-indole, triazolo-quinazoline derivatives for the preparation of pharmaceutical compositions preventing or treating diseases associated with an excess in il-12 production
HUP0402283A3 (en)	2009-07-28	Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
DK1459748T3 (da)	2005-07-04	(S,S)-reboxetin til behandling af perifer neuropati
CA2420056A1 (en)	2002-03-28	1-amino-alkylcyclohexanes as trypanocidal agents
WO2003064394A8 (de)	2003-12-24	5-ring heterozyklen zur verwendung als antiviral mittel
MXPA03008636A (es)	2003-12-08	Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.

Legal Events

Date	Code	Title	Description
2010-08-23	MM1K	Lapsed by not paying the annual fees